PACS Group, Inc. (NYSE:PACS) Receives Average Recommendation of “Moderate Buy” from Brokerages

PACS Group, Inc. (NYSE:PACSGet Free Report) has been given a consensus rating of “Moderate Buy” by the five brokerages that are covering the firm, Marketbeat.com reports. Two research analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 1-year price objective among brokerages that have issued ratings on the stock in the last year is $44.50.

PACS has been the topic of a number of research reports. Royal Bank Of Canada increased their price objective on PACS Group from $47.00 to $52.00 and gave the stock an “outperform” rating in a report on Friday. UBS Group restated a “buy” rating and set a $42.00 price target (down from $50.00) on shares of PACS Group in a research note on Thursday, December 18th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of PACS Group in a research note on Monday, December 22nd. Truist Financial set a $40.00 price objective on shares of PACS Group in a report on Friday, December 12th. Finally, JPMorgan Chase & Co. initiated coverage on PACS Group in a report on Wednesday, December 17th. They set an “overweight” rating and a $44.00 target price on the stock.

Read Our Latest Analysis on PACS

PACS Group Stock Performance

Shares of PACS stock opened at $36.63 on Monday. PACS Group has a fifty-two week low of $7.50 and a fifty-two week high of $43.08. The stock’s 50-day moving average is $38.16 and its two-hundred day moving average is $24.44. The company has a debt-to-equity ratio of 0.28, a current ratio of 0.94 and a quick ratio of 0.94. The firm has a market cap of $5.74 billion, a P/E ratio of 29.78, a PEG ratio of 1.22 and a beta of -0.63.

Institutional Investors Weigh In On PACS Group

Several institutional investors and hedge funds have recently added to or reduced their stakes in PACS. Vanguard Group Inc. grew its holdings in PACS Group by 14.4% during the fourth quarter. Vanguard Group Inc. now owns 4,506,227 shares of the company’s stock valued at $172,994,000 after purchasing an additional 566,502 shares during the last quarter. Alyeska Investment Group L.P. boosted its holdings in shares of PACS Group by 159.5% during the 4th quarter. Alyeska Investment Group L.P. now owns 2,250,007 shares of the company’s stock worth $86,378,000 after buying an additional 1,382,984 shares during the period. Crewe Advisors LLC grew its stake in PACS Group by 93.1% in the 4th quarter. Crewe Advisors LLC now owns 2,147,815 shares of the company’s stock valued at $82,455,000 after buying an additional 1,035,747 shares during the last quarter. Royce & Associates LP raised its holdings in PACS Group by 76.6% in the 3rd quarter. Royce & Associates LP now owns 1,859,070 shares of the company’s stock worth $25,525,000 after acquiring an additional 806,446 shares during the period. Finally, Balyasny Asset Management L.P. raised its holdings in PACS Group by 67.3% in the 3rd quarter. Balyasny Asset Management L.P. now owns 1,356,240 shares of the company’s stock worth $18,621,000 after acquiring an additional 545,348 shares during the period.

PACS Group News Roundup

Here are the key news stories impacting PACS Group this week:

  • Positive Sentiment: Analyst upgrade and higher price target: RBC raised its price target to $52 and kept an “outperform” rating, implying sizable upside vs. the current price — a catalyst that can support buying interest. Benzinga
  • Positive Sentiment: Management outlined an 8% revenue growth target for 2026 and said integration activity is driving a record year — suggests revenue runway and margin improvement from recent acquisitions. PACS Group outlines 8% revenue growth target for 2026
  • Positive Sentiment: Operational quality signals: company highlights zero-deficiency surveys, high occupancy and 73% of facilities with top-tier star ratings — supports sustained revenue and reimbursement stability. Skilled Nursing News
  • Positive Sentiment: FY2026 revenue guidance was updated above consensus ($5.7–$5.8B vs. ~$5.6B consensus), which is constructive if sustained. (Company press release & slide deck provided.) Press Release / Slide Deck
  • Neutral Sentiment: Company released full fiscal year and Q4 2025 results and hosted the earnings call; slides and transcript are available for detailed line-item review. Yahoo Finance Earnings Call Transcript
  • Negative Sentiment: Mixed-to-weaker quarter headlines pressured the stock: some outlets reported EPS below expectations (Zacks noted $0.43 vs. $0.48 est.), and others highlighted revenue slightly under consensus — these reports triggered the technical break below the 50-day moving average and heavier selling. Investors.com Zacks
  • Negative Sentiment: Technical and flow risk: share price decline through the 50-day MA and volume roughly triple average increase near-term downside risk as traders react to perceived earnings weakness. Investors.com technical note

PACS Group Company Profile

(Get Free Report)

PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.

Featured Stories

Analyst Recommendations for PACS Group (NYSE:PACS)

Receive News & Ratings for PACS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PACS Group and related companies with MarketBeat.com's FREE daily email newsletter.